Last reviewed · How we verify

Banxiaxiexin decoction — Competitive Intelligence Brief

Banxiaxiexin decoction (Banxiaxiexin decoction) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Traditional Chinese medicine herbal decoction. Area: Respiratory/Gastrointestinal.

phase 3 Traditional Chinese medicine herbal decoction Respiratory/Gastrointestinal Small molecule Live · refreshed every 30 min

Target snapshot

Banxiaxiexin decoction (Banxiaxiexin decoction) — Nanjing First Hospital, Nanjing Medical University. Banxiaxiexin decoction is a traditional Chinese medicine formulation that modulates inflammatory and immune responses to treat respiratory and gastrointestinal conditions.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Banxiaxiexin decoction TARGET Banxiaxiexin decoction Nanjing First Hospital, Nanjing Medical University phase 3 Traditional Chinese medicine herbal decoction

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Traditional Chinese medicine herbal decoction class)

  1. Nanjing First Hospital, Nanjing Medical University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Banxiaxiexin decoction — Competitive Intelligence Brief. https://druglandscape.com/ci/banxiaxiexin-decoction. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: